{
    "2021-08-12": [
        [
            {
                "time": "",
                "original_text": "500亿明星基金经理“踩雷”医药股！泓德基金邬传雁旗下产品全线告亏，最大回撤23% 重仓股票异动",
                "features": {
                    "keywords": [
                        "明星基金经理",
                        "踩雷",
                        "医药股",
                        "泓德基金",
                        "邬传雁",
                        "全线告亏",
                        "最大回撤"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "泓德基金权益产品表现不佳幕后：邬传雁“明星效应陨落”引发行业反思",
                "features": {
                    "keywords": [
                        "泓德基金",
                        "权益产品",
                        "表现不佳",
                        "明星效应陨落",
                        "行业反思"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "北向资金交投趋谨慎全天净卖出不足2亿，贵州茅台连续11日遭抛售",
                "features": {
                    "keywords": [
                        "北向资金",
                        "交投趋谨慎",
                        "净卖出",
                        "贵州茅台",
                        "连续抛售"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "白酒"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "“茅指数”“宁组合”全线急杀，成长股要变天？",
                "features": {
                    "keywords": [
                        "茅指数",
                        "宁组合",
                        "全线急杀",
                        "成长股"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "新能源",
                        "消费"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "恒瑞医药：长效抗菌药注射用HRS9432获批临床",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "长效抗菌药",
                        "HRS9432",
                        "获批临床"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "A股融资融券日报：两融余额增加75.25亿元（8月11日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额",
                        "增加"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "再鼎医药半年报：“License-in”喜忧参半",
                "features": {
                    "keywords": [
                        "再鼎医药",
                        "半年报",
                        "License-in",
                        "喜忧参半"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "财信证券医药生物行业2021年8月月度报告：坚守高景气，关注高性价比个股",
                "features": {
                    "keywords": [
                        "财信证券",
                        "医药生物",
                        "高景气",
                        "高性价比个股"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}